Literature DB >> 25071928

New trends in aminoglycosides use.

Marina Y Fosso1, Yijia Li1, Sylvie Garneau-Tsodikova1.   

Abstract

Despite their inherent toxicity and the acquired bacterial resistance that continuously threaten their long-term clinical use, aminoglycosides (AGs) still remain valuable components of the antibiotic armamentarium. Recent literature shows that the AGs' role has been further expanded as multi-tasking players in different areas of study. This review aims at presenting some of the new trends observed in the use of AGs in the past decade, along with the current understanding of their mechanisms of action in various bacterial and eukaryotic cellular processes.

Entities:  

Year:  2014        PMID: 25071928      PMCID: PMC4111210          DOI: 10.1039/C4MD00163J

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  215 in total

1.  Highly modular structure and ligand binding by conformational capture in a minimalistic riboswitch.

Authors:  Elke Duchardt-Ferner; Julia E Weigand; Oliver Ohlenschläger; Sina R Schmidtke; Beatrix Suess; Jens Wöhnert
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-16       Impact factor: 15.336

2.  Antibacterial activity of guanidinylated neomycin B- and kanamycin A-derived amphiphilic lipid conjugates.

Authors:  Smritilekha Bera; George G Zhanel; Frank Schweizer
Journal:  J Antimicrob Chemother       Date:  2010-03-23       Impact factor: 5.790

3.  Aminoglycoside-induced reduction in nucleotide mobility at the ribosomal RNA A-site as a potentially key determinant of antibacterial activity.

Authors:  Malvika Kaul; Christopher M Barbieri; Daniel S Pilch
Journal:  J Am Chem Soc       Date:  2006-02-01       Impact factor: 15.419

4.  Site-selective displacement of tobramycin hydroxyls for preparation of antimicrobial cationic amphiphiles.

Authors:  Yifat Berkov-Zrihen; Ido M Herzog; Mark Feldman; Micha Fridman
Journal:  Org Lett       Date:  2013-11-13       Impact factor: 6.005

5.  Mitochondria-targeted antioxidant SkQR1 ameliorates gentamycin-induced renal failure and hearing loss.

Authors:  S S Jankauskas; E Y Plotnikov; M A Morosanova; I B Pevzner; L D Zorova; V P Skulachev; D B Zorov
Journal:  Biochemistry (Mosc)       Date:  2012-06       Impact factor: 2.487

6.  Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7.

Authors:  Kyoung Hoon Kim; Doo Ri An; Jinsu Song; Ji Young Yoon; Hyoun Sook Kim; Hye Jin Yoon; Ha Na Im; Jieun Kim; Do Jin Kim; Sang Jae Lee; Ki-Hye Kim; Hye-Mi Lee; Hie-Joon Kim; Eun-Kyeong Jo; Jae Young Lee; Se Won Suh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

Review 7.  Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.

Authors:  Mariana Hainrichson; Igor Nudelman; Timor Baasov
Journal:  Org Biomol Chem       Date:  2007-10-09       Impact factor: 3.876

8.  Structural basis for aminoglycoside inhibition of bacterial ribosome recycling.

Authors:  Maria A Borovinskaya; Raj D Pai; Wen Zhang; Barbara S Schuwirth; James M Holton; Go Hirokawa; Hideko Kaji; Akira Kaji; Jamie H Doudna Cate
Journal:  Nat Struct Mol Biol       Date:  2007-07-29       Impact factor: 15.369

9.  Two-dimensional combinatorial screening and the RNA Privileged Space Predictor program efficiently identify aminoglycoside-RNA hairpin loop interactions.

Authors:  Dustin J Paul; Steven J Seedhouse; Matthew D Disney
Journal:  Nucleic Acids Res       Date:  2009-09-02       Impact factor: 16.971

10.  In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.

Authors:  Isabelle Sermet-Gaudelus; Michel Renouil; Anne Fajac; Laure Bidou; Bastien Parbaille; Sébastien Pierrot; Nolwen Davy; Elise Bismuth; Philippe Reinert; Gérard Lenoir; Jean François Lesure; Jean Pierre Rousset; Aleksander Edelman
Journal:  BMC Med       Date:  2007-03-29       Impact factor: 8.775

View more
  30 in total

1.  Amphiphilic Tobramycin Analogues as Antibacterial and Antifungal Agents.

Authors:  Sanjib K Shrestha; Marina Y Fosso; Keith D Green; Sylvie Garneau-Tsodikova
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

2.  Tobramycin Variants with Enhanced Ribosome-Targeting Activity.

Authors:  Marina Y Fosso; Hongkun Zhu; Keith D Green; Sylvie Garneau-Tsodikova; Kurt Fredrick
Journal:  Chembiochem       Date:  2015-06-17       Impact factor: 3.164

3.  Concurrent hearing and genetic screening in a general newborn population.

Authors:  Ling Guo; Jiale Xiang; Lei Sun; Xinyi Yan; Jingjing Yang; Haiyan Wu; Kejian Guo; Jiguang Peng; Xiaomei Xie; Ye Yin; Jian Wang; Huanming Yang; Jun Shen; Lijian Zhao; Zhiyu Peng
Journal:  Hum Genet       Date:  2020-01-30       Impact factor: 4.132

4.  High throughput LSPR and SERS analysis of aminoglycoside antibiotics.

Authors:  Kristy S McKeating; Maxime Couture; Marie-Pier Dinel; Sylvie Garneau-Tsodikova; Jean-Francois Masson
Journal:  Analyst       Date:  2016-08-15       Impact factor: 4.616

5.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

6.  Expanding Aminoglycoside Resistance Enzyme Regiospecificity by Mutation and Truncation.

Authors:  Selina Y L Holbrook; Sylvie Garneau-Tsodikova
Journal:  Biochemistry       Date:  2016-09-26       Impact factor: 3.162

Review 7.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

8.  Polybasic peptide-levofloxacin conjugates potentiate fluoroquinolones and other classes of antibiotics against multidrug-resistant Gram-negative bacteria.

Authors:  Liam Berry; Ronald Domalaon; Marc Brizuela; George G Zhanel; Frank Schweizer
Journal:  Medchemcomm       Date:  2019-03-07       Impact factor: 3.597

9.  Synthesis and Biological Activity of Mono- and Di-N-acylated Aminoglycosides.

Authors:  Nishad Thamban Chandrika; Keith D Green; Jacob L Houghton; Sylvie Garneau-Tsodikova
Journal:  ACS Med Chem Lett       Date:  2015-09-30       Impact factor: 4.345

10.  Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.

Authors:  Marina Y Fosso; Sanjib K Shrestha; Keith D Green; Sylvie Garneau-Tsodikova
Journal:  J Med Chem       Date:  2015-12-01       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.